Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 125,950 shares at $23.23 ($2.9M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $2.9M CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.93 | 53,255 | $1.2M | 42.2% |
| 2 | $22.93 | 53,255 | $1.2M | 42.2% |
| 3 | $23.23 | 9,720 | $226K | 7.8% |
| 4 | $23.23 | 9,720 | $226K | 7.8% |
| Total | $22.98 avg | 125,950 | $2.9M | 100% |
| Filing → |
| CPRX | SELL | 2025-09-05 | $1.4M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |
| CPRX | SELL | 2024-03-28 | $822K | — | Filing → |